HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peiqi Chen Selected Research

Teriparatide (Parathar)

5/2012Consistency of fracture risk reduction in Japanese and Caucasian osteoporosis patients treated with teriparatide: a meta-analysis.
4/2011PINP as an aid for monitoring patients treated with teriparatide.
4/2010Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
4/2010Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
6/2009Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
12/2008Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)].
9/2007Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide.
8/2007Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.
11/2006Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
2/2006Reduced risk of back pain following teriparatide treatment: a meta-analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peiqi Chen Research Topics

Disease

17Osteoporosis
05/2012 - 06/2005
4Neoplasms (Cancer)
04/2020 - 12/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2020 - 01/2017
3Back Pain (Backache)
02/2006 - 08/2005
2Postmenopausal Osteoporosis
01/2006 - 06/2005
1Neoplasm Metastasis (Metastasis)
04/2020
1Fatigue
01/2020
1Adenocarcinoma of Lung
01/2020
1Diarrhea
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Adenocarcinoma
01/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Acquired Immunodeficiency Syndrome (AIDS)
04/2011
1Bone Neoplasms (Bone Cancer)
12/2008
1Osteosarcoma (Osteogenic Sarcoma)
12/2008
1Hypercalciuria
09/2007
1Osteoporotic Fractures
02/2006
1Bone Resorption
06/2005

Drug/Important Bio-Agent (IBA)

14Teriparatide (Parathar)FDA Link
05/2012 - 06/2005
4Biomarkers (Surrogate Marker)IBA
04/2011 - 06/2005
4Alendronate (Alendronate Sodium)FDA LinkGeneric
04/2010 - 08/2005
2GlucocorticoidsIBA
04/2010 - 04/2010
2Raloxifene Hydrochloride (Evista)FDA Link
06/2009 - 10/2008
2Pharmaceutical PreparationsIBA
09/2007 - 02/2006
1ErbB Receptors (EGF Receptor)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2017
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2017
1Carboplatin (JM8)FDA LinkGeneric
01/2017
1methylene diphosphonateIBA
05/2010
1Procollagen Type IIBA
04/2010
1OsteocalcinIBA
04/2010
1CalciumIBA
09/2007
1Alkaline PhosphataseIBA
06/2005
1Peptides (Polypeptides)IBA
06/2005
1procollagen type I carboxy terminal peptide (PICP)IBA
06/2005
1ProcollagenIBA
06/2005
1deoxypyridinolineIBA
06/2005

Therapy/Procedure

5Therapeutics
04/2020 - 06/2005
3Adjuvant Chemotherapy
04/2020 - 01/2017
3Drug Therapy (Chemotherapy)
04/2020 - 01/2018
2Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2020 - 01/2017
1Aftercare (After-Treatment)
04/2020
1Maintenance Chemotherapy
01/2018
1Withholding Treatment
12/2008
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
02/2006
1Subcutaneous Injections
06/2005